The role of pharmaceutical intermediates buyers is fraught with challenges. One significant issue is the volatility of the raw materials market. Prices can fluctuate due to geopolitical tensions, supply chain disruptions, or even natural disasters. Buyers must be adept at risk management and contingency planning to mitigate these risks while ensuring that their company remains competitive.
As industries continue to evolve and strive for sustainable practices, the demand for compounds like ethylene diformate is expected to rise. Research is ongoing to explore new synthesis routes and leverage EDF’s properties in novel applications. Furthermore, efforts to enhance its efficiency and reduce production costs can bolster its competitiveness in the market.
In 2020, the growth of China’s API export was stimulated by the epidemic, which boosted the global demand for ANTI-epidemic APIS, and also affected the production of other major API producers such as India and the European Union. As a result, the transfer orders of China’s API from the international market increased. Specifically, the export quantity of China’s API increased by 7.5% year on year, reaching 10.88 million tons. From specific export category, anti-infection, vitamins, hormones, antipyretic analgesic, part of antibiotic resistance to disease related API category of export amount is mostly realized the different levels of growth, some specific varieties is growing rapidly, such as dexamethasone exports rose 55% year-on-year, lamivudine, vitamin C, vitamin E and other exports more than 30% year-on-year growth, Paracetamol, annannin and other exports year-on-year growth of more than 20%.
For those considering adding active supplements to their routine, it is advisable to consult with a healthcare professional, especially if you have underlying health conditions or are taking medications. A healthcare provider can help determine which supplements, if any, are suitable based on individual health needs and goals.